This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. Read our cookie policy for more information. Click here to accept the use of cookies on our website. Careers Contact us About Us Product Pipeline Research and Technology Partnering Investors Media Contact Us Careers Privacy Innovating antibodies, improving lives Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. 2018 Capital Markets Day Genmab hosted a Capital Markets Day on September 26, 2018 in person at our R&D Center in Utrecht, the Netherlands and via live webcast. The meeting featured a number of management level Genmab speakers who provided updates on Genmab’s business including the clinical and pre-clinical pipelines, proprietary next generation antibody technologies and R&D capabilities. Click here to listen to the replay of the webcast. Click here to view the presentation. Career Opportunities at Genmab Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn. Genmab is on Twitter Find Genmab on Twitter at @Genmab and @GenmabR_D Latest News Genmab's 2018 Capital Markets Day Genmab's Financial Calendar for 2019 Genmab to Host Capital Markets Day Genmab to Present at Morgan Stanley 16th Annual Global Healthcare Conference More Genmab News Releases Our Strategy Click here to watch a video about our strategy. Stock Info Accessibility policy Cookie policy Disclaimer Privacy Sitemap © 2018 Genmab A/S